
Researchers at Stanford and the Arc Institute have successfully used AI to design viruses that are not found in nature, aiming to combat drug-resistant bacterial infections. The AI models, Evo 1 and Evo 2, were trained on millions of genomes to create new versions of the Phi X174 virus, resulting in 16 viable viruses. These AI-designed viruses were able to eliminate E. coli strains resistant to natural viruses. While the development is a significant step forward in addressing antibiotic resistance, it also underscores the need for careful regulation to prevent potential misuse.
Read originalTopicAI Designed VirusesCooling
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
WIRED AI · April 29, 2026 · Related
MIT News AI · May 20, 2026 · Background
OpenAI · June 4, 2026 · Background
The Verge AI · June 4, 2026 · Background
Crunchbase News · July 10, 2026 · Background
Google DeepMind · July 16, 2026 · Background
MIT Technology Review AI · July 23, 2026 · Background
MIT Technology Review AI · July 27, 2026 · Related
The Rundown AI · August 20, 2026 · Background
MIT News AI · August 27, 2026 · Background
OpenAI · September 10, 2026 · Related
WIRED AI · September 18, 2026 · Background
Wes Roth · September 24, 2026 · Background
AI Designs Novel Viruses to Combat Drug Resistance
5 developments